EDURANT

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug EDURANT contains one active pharmaceutical ingredient (API):

1 Rilpivirine UNII 212WAX8KDD - RILPIVIRINE HYDROCHLORIDE

Rilpivirine is a diarylpyrimidine NNRTI of HIV-1. Rilpivirine activity is mediated by non-competitive inhibition of HIV-1 reverse transcriptase (RT). Rilpivirine does not inhibit the human cellular DNA polymerases α, β and γ. Read about Rilpivirine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EDURANT Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AG05	Rilpivirine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AG Non-nucleoside reverse transcriptase inhibitors
Discover more medicines within J05AG05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10298B
Country: CA	Health Products and Food Branch	Identifier(s): 02370603
Country: EE	Ravimiamet	Identifier(s): 1550720
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 11736001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 189148
Country: FR	Base de données publique des médicaments	Identifier(s): 63025141
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 198427
Country: HK	Department of Health Drug Office	Identifier(s): 61376
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7066
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1064181
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 101559
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15313
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100261312
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W58157001
Country: SG	Health Sciences Authority	Identifier(s): 14363P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699593095375
Country: US	FDA, National Drug Code	Identifier(s): 59676-278
Country: ZA	Health Products Regulatory Authority	Identifier(s): 46/20.2.8/0793